Gerard Gregg-Smith invests in companies in Life Sciences, Cleantech, and other sectors, and is available for non-executive and other roles.

He started his career with 10 years in the pharmaceutical industry, initially with Chugai Pharmaceutical (now part of Roche) in Japan, then with Glaxo (now GSK) in the UK. He then worked for 15 years in investment banking (mergers and acquisitions), living and working in three continents, starting with Baring Brothers in London, then Japan for another 5 years, then New York for 3 years, and culminating by joining KPMG Corporate Finance as a Partner.

He then established his own business, GGS Associates, in 2006.

He has raised capital for a number of companies, from early-stage start-ups to profitable companies with valuations over £100m.

He has appointed a number of CEOs, CFOs, Business Development and other senior executives and board directors in Europe, Asia and the US.

He has been a mentor and judge at a number of competitions including MassChallenge, Open Accelerator, Cleantech Challenge, HealthTech Challenge, and MedTech SuperConnector, and an Innovate UK Assessor.

Thang Vo-Ta, is the CEO of Calla Lily Clinical Care, a medical device startup that he co-founded with Dr. Lara Zibners, a former emergency room pediatrician inspired by Lara’s experience from multiple failed IVF cycles - involving hundreds of painful intramuscular injections and leaky pessaries. As the CEO he manages the team and sets its strategic direction, including its commitment to the environment, people and communities as a certified B Corp.

Thang started his career in investment banking & private equity in the NY and London offices at Goldman Sachs, followed by a decade in property acquisition and development, working on London landmarks including St Pancras Chambers & Chiltern Firehouse. Thang has been named a Sunday Times Maserati Top 100 entrepreneur and The Manufacturer's Top 100 manufacturing leader. He has a BSc in management from MIT, is completing a translational health MSc at University of Oxford, and lives in London with his wife and four children.

Eva is passionate about equality in access to innovation, women's health, and female leadership empowerment. Rooted in her belief that healthcare is a fundamental human right, Eva co-founded Nostics, a data-driven diagnostics company with a mission to make AI-enabled testing for infectious diseases accessible worldwide.

Lucie Wellington is a Senior Innovation Advisor at Imperial College Health Partners, where she plays a key role in designing and delivering high-impact innovation and improvement programmes to enhance health outcomes across North West London. With over 10 years of NHS experience, she has a strong background in physiotherapy, specialising in working with older people, and continues to practise clinically.

Driven by a passion for system-wide transformation, Lucie completed an Improvement and Innovation Fellowship at Chelsea and Westminster Hospital NHS Foundation Trust in 2020. She went on to become Lead Physiotherapist for Medicine and Frailty at West Middlesex University Hospital, where she delivered organisation-wide service improvement programmes in sepsis recognition and delirium management.

At Imperial College Health Partners, Lucie has led system-wide innovation programmes, supporting industry with NHS implementation and evaluation across a range of speciality areas, including long-term conditions and system flow. She has a keen interest in digital health, older persons’ healthcare, and operational efficiency, leveraging her expertise to drive the adoption of innovative healthcare solutions.

Dr. Aaron Lin is the Co-Founder and Chief Operating Officer at Mindstep, a leading digital health front-door platform for mental health and neurological conditions.

Backed by leading VC's, Mindstep has raised over £5m to-date, and powers some of the world's largest payers and health providers.

Alongside his work at Mindstep, Aaron also serves as an NHS Clinical Entrepreneur, and was recently named the 2024 Social Impact Entrepreneur of the Year.

Dr. Christopher Wall is the CEO and founder of Cardiology Devices developing a device that offers a novel way to treat advanced heart failure. Their device Myocaid offers easier implantation to treat older, frailer patients.

Dr. Wall is a cardiology registrar at Clinical Research Training Fellow at the British Health Foundation. His entrepreneurship with Cardiology Devices has led to multiple awards including the Santander X Global Challenge and the London Business School HealthTech Challenge.

Simran Cashyap is the co-founder and partner of Pulse Angels, a dynamic angel syndicate connecting investors with healthtech pioneers to drive medical innovation. Simran is a seasoned leader and investor with a successful track record of scaling companies, leading high-performing teams, and launching high-quality products.

Operating in a wide variety of roles, with a specific focus on AI across data-intensive and information-heavy industries, Simran is experienced in leading cross-functional teams, coaching founders, launching successful products, and raising funds.

Simran is also the VP of Product at Echobox, an automation platform that helps business optimize their content. He received his executive MBA at London Business School.

Dr Ekanjali Dhillon is a healthcare leader with extensive experience in both the NHS and private healthcare sectors, specialising in digital transformation and health tech implementation in complex clinical environments.

As Digital Transformation Change Lead in Medicine and Oncology at HCA UK, she drives the integration of technology to optimise patient care and streamline healthcare operations. With a background as a physician and a track record of leading in healthcare projects, Dr Dhillon has expertise in navigating the challenges of clinical adoption, interoperability, and digital strategy in healthcare.

As a Board Trustee at Age UK (HHB), Dr Dhillon supports strategic innovation and the use of technology to improve care for older populations. Passionate about bridging the gap between clinical practice and health tech, Dr Dhillon brings insights on scaling digital solutions, navigating healthcare systems, and driving impactful change in patient care.

Benjamín Torrero is a Principal at Boost Capital Partners, a venture capital firm based in London that invests in pre-seed and seed-stage companies across finance, education, healthcare, and entertainment with a strong product and user experience focus. He is driven by a passion for supporting founders tackling the most pressing challenges in people’s lives—whether it's improving mental health, solving inefficiencies in healthcare, or expanding access to credit for underserved populations.

Benjamín is particularly interested in applying insights from human behavior to product development and innovation. Before joining Boost Capital Partners, he founded and led an Angel Syndicate focused on investing in entrepreneurs addressing inefficiencies in Latin America. Prior to his career in venture, he spent five years as a financial lawyer.

Dr. Matea Deliu, MD, PhD, MCRGP, is an academic GP, Clinical Lead for Primary Care Digital Delivery, and Clinical Safety Officer at the NHS South East London Integrated Care Board. In this capacity, she leads the digital transformation directorate, assessing and evaluating innovative digital tools to enhance primary care delivery while ensuring clinical safety. With a strong background in health informatics, Dr. Deliu utilises her PhD expertise to leverage population health data analytics for informed decision-making and improved patient outcomes. Her focus includes remote monitoring, AI, and proactive care.

Her leadership experience extends to her role as Associate Medical Director for One Health Lewisham, where she strategically managed a range of clinical services across South East and North East London. In addition to her NHS responsibilities, Dr. Deliu is a trusted health tech consultant. She helps startups navigate NHS regulatory frameworks, formulate robust digital strategies, and ensure their solutions meet clinical safety standards for adoption within the NHS.

Madeleine Nichols is a founder-turned-VC at Empirical, a specialist venture capital firm and venture builder backing Europe’s leading early-stage deep-tech ventures.

Maddy’s background is rooted in research—she holds a PhD in acoustic micro-fabrication from the University of Bristol and a Master’s degree in Physics from the University of Manchester. After completing her PhD in functional nanomaterials, she transitioned into the world of startups, initially supporting science researchers with commercialization and innovation training. This led her to work closely with academic founders, helping to build deep-tech ventures as COO of Spin Up Science.

While at Spin Up, Maddy co-founded Protolyst, a software platform designed to help founders organize and track key insights while building their ventures. After three years leading Protolyst, she joined Empirical Ventures as an Investment Associate in early 2024, bringing her experience as both a researcher and operator to help shape the next generation of deep-tech startups.

Jenny is known for making digital innovation in healthcare happen. In 2016, Jenny set up and led DigitalHealth.London from scratch to an award winning force in UK healthcare. DigitalHealth.London is best known for its accelerator programme which supports businesses to better navigate and gain traction in the NHS. It also includes a portfolio of other successful programmes such as the Pioneer Fellowship which supports NHS staff to adopt innovations faster and more effectively.

Jenny worked as the General Manager for Womens at Guy's and St Thomas' whilst completing her MBA at London Business School. During this time she collaborated with LBS to host the first ever LBS - NHS consulting projects for MBA students. Jenny has had the pleasure of judging many health tech start-up competitions, including the LBS Health Tech Challenge and Rewired. Over the past few years Jenny has freelanced in senior commercial, operational and partnership roles for many well-known health tech start-ups including Doccla, Oviva, DrDoctor, and Peppy.

Omar is a former healthcare management consultant turned healthtech entrepreneur and venture capital investor. Omar has since built a career dedicated to healthcare innovation.

After successfully scaling his startup to reach 25% of the NHS Primary Care market in just 18 months, he now leads an angel syndicate focused on early-stage healthtech startups. He is a board member of NHS South West London ICB and is also a mentor to healthtech founders, an assessor for Innovate UK, and an advisor to NHS England and the Tony Blair Institute for Global Change. Most recently, he launched the UK’s first Primary Care Innovation Accelerator, supporting the adoption of healthcare innovations across the UK.

June Angelides MBE is a Venture Partner at Samos Investments, where she has been investing since 2018, bringing over 13 years of experience across venture debt, venture capital, and entrepreneurship. She began her career at Silicon Valley Bank, working on the Venture Debt and Early-Stage Banking teams, before launching her own startup, which she ran for three years before transitioning into investing.

At Samos, June focuses on backing transformative businesses, including several pioneering healthcare startups such as Micrographia, Lantum, Lighthearted AI, and Level Zero Health, all of which are driving innovation in healthtech and life sciences.

Beyond her work at Samos, June is an active angel investor with a growing portfolio of women-led businesses and a passionate advocate for diversity in venture and technology. She sits on the boards of Jude, Flair, Ruka, and Everpress, mentors founders at Oxford University, and runs mentoring circles for aspiring VCs and entrepreneurs. Previously, she founded Mums in Tech, the UK’s first child-friendly coding school, which helped over 250 women learn to code.

A recognized thought leader in venture and innovation, June was a Columnist at the Financial Times and served on the UK Government’s Taskforce on Women-Led High-Growth Enterprises, working to break investment barriers for women entrepreneurs. She has been named one of the Most Influential Tech Leaders by the Financial Times and one of Computer Weekly’s Most Influential Women in Tech.
June holds an Honorary Fellowship from the Institute of Engineering and Technology and was awarded an MBE for services to women in technology. She is passionate about fostering innovation in healthcare and looks forward to supporting the next wave of groundbreaking solutions as a judge at this conference.

Gail is the founding partner of Lavender Ventures, a fund dedicated to investing in early-stage female health and wellbeing companies. Passionate about empowering women and advancing female health, she brings a unique blend of expertise from both corporate and startup/scale up environments.

Previously, Gail was a managing director at Accenture, with extensive experience in scale-ups, economic development, and a Masters in International Business.

She is also a proud member of the femella Advisory Board, a membership organisation that supports young professional women in reaching their full potential. Beyond her professional endeavours, Gail is an ultramarathon runner and the author of a book on nutrition.